ArticleFrontiers in oncology2026

A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death.

A-Yeon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.